Development of Ipilimumab: Contribution to a New Paradigm for Cancer Immunotherapy
- 1 October 2010
- journal article
- review article
- Published by Elsevier in Seminars in Oncology
- Vol. 37 (5) , 533-546
- https://doi.org/10.1053/j.seminoncol.2010.09.015
Abstract
No abstract availableKeywords
Funding Information
- Bristol-Myers Squibb Co
This publication has 67 references indexed in Scilit:
- Betting on immunotherapy for melanomaCurrent Oncology Reports, 2009
- Immune Therapy for CancerAnnual Review of Immunology, 2009
- Principles of Cancer Therapy: Oncogene and Non-oncogene AddictionCell, 2009
- Immunotherapy for Advanced MelanomaJournal of Investigative Dermatology, 2008
- Next Generation of Immunotherapy for MelanomaJournal of Clinical Oncology, 2008
- A Clinical Development Paradigm for Cancer Vaccines and Related BiologicsJournal of Immunotherapy, 2007
- The Three Es of Cancer ImmunoeditingAnnual Review of Immunology, 2004
- Immunotherapy: past, present and futureNature Medicine, 2003
- The Concept of Immunological SurveillancePublished by S. Karger AG ,1969
- Cancer--A Biological Approach: III. Viruses Associated with Neoplastic Conditions. IV. Practical ApplicationsBMJ, 1957